More than 100 pharmaceutical companies in India have failed quality tests for their cough syrups, revealing the presence of toxins linked to the deaths of over 141 children in Gambia, Cameroon, and Uzbekistan. The Indian government has implemented stricter manufacturing standards and is enhancing export certification processes to address concerns about the quality and safety of its pharmaceutical products.